Oncology Institute Inc. (TOI)
NASDAQ: TOI
· Real-Time Price · USD
2.37
0.03 (1.28%)
At close: Jun 18, 2025, 3:59 PM
1.28% (1D)
Bid | 2.34 |
Market Cap | 210.94M |
Revenue (ttm) | 403.15M |
Net Income (ttm) | -67.98M |
EPS (ttm) | -0.7 |
PE Ratio (ttm) | -3.38 |
Forward PE | -25.78 |
Analyst | Buy |
Ask | 2.39 |
Volume | 892,829 |
Avg. Volume (20D) | 1,547,652 |
Open | 2.29 |
Previous Close | 2.34 |
Day's Range | 2.29 - 2.46 |
52-Week Range | 0.13 - 3.50 |
Beta | 0.16 |
Analyst Forecast
According to 0 analyst ratings, the average rating for TOI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+28.27%
The Oncology Institute shares are trading higher a...
Unlock content with
Pro Subscription
1 month ago
-10.57%
The Oncology Institute shares are trading higher after the company reported a year-over-year increase in Q1 financial results.

1 month ago · seekingalpha.com
The Oncology Institute, Inc. (TOI) Q1 2025 Earnings Call TranscriptThe Oncology Institute, Inc. (NASDAQ:TOI ) Q1 2025 Earnings Conference Call May 14, 2025 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - Chief Executive Officer ...

2 months ago · seekingalpha.com
The Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call TranscriptThe Oncology Institute, Inc. (NASDAQ:TOI ) Q4 2024 Earnings Conference Call March 25, 2025 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - CEO Rob Carter - CFO C...